Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × Resistance Training × 30 days × Clear all

Sponsor

Conditions

Obesity 2 Motor Activity 2 Thrombocythemia, Essential 1 Skin Neoplasms 1 Sarcopenia 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Overweight 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Hematopoietic and Lymphatic System Neoplasm 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

venetoclax 48 Cytarabine 35 Azacitidine 34 Specimen Handling 32 Biopsy 21 Daunorubicin 14 fludarabine 12 Idarubicin 12 Injections 10 Decitabine 10 decitabine and cedazuridine drug combination 9 Cyclophosphamide 9 gilteritinib 8 fludarabine phosphate 8 Magnetic Resonance Spectroscopy 8 Granulocyte Colony-Stimulating Factor 8 Cladribine 8 X-Rays 6 Busulfan 6 Whole-Body Irradiation 5 Stem Cell Transplantation 5 Mitoxantrone 5 Melphalan 5 CPX-351 5 revumenib 4 Tacrolimus 4 ruxolitinib 3 quizartinib 3 olutasidenib 3 enasidenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡